Kelly Shi
Stock Analyst at Jefferies
(3.32)
# 1,245
Out of 5,176 analysts
35
Total ratings
47.83%
Success rate
19.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Buy | $252 → $290 | $220.90 | +31.28% | 3 | Mar 16, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $8.07 | +11.52% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $78.93 | +54.57% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $66.75 | +15.36% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $148.31 | -0.21% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $36.50 | -23.29% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $17.94 | +145.26% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $5.09 | +194.70% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.35 | +522.75% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.93 | +183.98% | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $19 | $28.22 | -32.67% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $5.50 | +281.82% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $24.20 | +52.89% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $1.83 | +227.87% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $92.23 | -12.18% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.74 | +53.91% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.78 | +1,194.96% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $18.02 | -11.21% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $15.71 | +27.31% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $6.81 | +6,243.61% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.16 | +267.23% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $3.36 | +703.57% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $4.07 | +710.81% | 1 | Mar 8, 2021 |
Ascendis Pharma
Mar 16, 2026
Assumes: Buy
Price Target: $252 → $290
Current: $220.90
Upside: +31.28%
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $8.07
Upside: +11.52%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $78.93
Upside: +54.57%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $66.75
Upside: +15.36%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $148.31
Upside: -0.21%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $36.50
Upside: -23.29%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $17.94
Upside: +145.26%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $5.09
Upside: +194.70%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.35
Upside: +522.75%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.93
Upside: +183.98%
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $28.22
Upside: -32.67%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $5.50
Upside: +281.82%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $24.20
Upside: +52.89%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $1.83
Upside: +227.87%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $92.23
Upside: -12.18%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $22.74
Upside: +53.91%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.78
Upside: +1,194.96%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $18.02
Upside: -11.21%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $15.71
Upside: +27.31%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $6.81
Upside: +6,243.61%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.16
Upside: +267.23%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $3.36
Upside: +703.57%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $4.07
Upside: +710.81%